Dec 21, 2022

Featuring a slide presentation and related discussion from Dr Thomas Herzog, including the following topics:

• Keys to evaluating genetics in patients with ovarian cancer (0:00)
• Clinical trials evaluating PARP inhibitor maintenance therapy for patients with newly diagnosed ovarian cancer responding to platinum-based chemotherapy (7:35)
• Current status of PARP inhibitor use in the care of patients with ovarian cancer (18:45)
• Ongoing studies evaluating the combination of PARP and immune checkpoint inhibitors (24:37)

CME information and select publications